Reasons for Palliative Treatments in Stage III Non-Small-Cell Lung Cancer: What Contribution Is Made by Time-Dependent Changes in Tumour or Patient Status?

Abstract

A significant proportion of patients receive palliative therapy for stage iii nsclc because of changes that occur during the diagnostic journey. Shortening or altering that pathway to avoid tumour growth or patient deterioration during care could allow for more patients to be treated with curative intent.